Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Drug Intelligence & Clinical Pharmacy|April 1, 1984
Phenytoin-folic acid: a reviewM P Rivey, D D Schottelius, M J BergNeurology|May 1, 1985
Bilateral focal cortical atrophy and chronic ergotamine abuseR W Fincham, Z Perdue, V D DunnNeurology|December 1, 1975
Alexia with left homonymous hemianopia without agraphia. A case report with autopsy findingsR W Fincham, D W Nibbelink, C A AschenbrenerThe Annals of Pharmacotherapy|February 1, 1992
Parkinsonism treatment: Part III--UpdateD S Collier, M J Berg, R W FinchamTherapeutic Drug Monitoring|September 1, 1987
Utilization of Km for phenytoin dosage after folate addition to patient regimenM J Berg, B E Ebert, M P Rivey, et al.Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1986
Linear systems approach to the analysis of an induced drug removal process. Phenobarbital removal by oral activated charcoalW R Gillespie, P Veng-Pedersen, M J Berg, et al.Journal of the American College of Cardiology|March 15, 1990
Bradycardia and syncope as manifestations of partial epilepsyL Constantin, J B Martins, R W Fincham, et al.Neurofibromatosis|January 1, 1988
Ventriculomegaly in neurofibromatosis-1. Association with Chiari type I malformationA K Afifi, K D Dolan, J C Van Gilder, et al.Pharmaceutical Research|January 1, 1992
Surface characterization of activated charcoal by X-ray photoelectron spectroscopy (XPS): correlation with phenobarbital adsorption dataG M Burke, D E Wurster, M J Berg, et al.Therapeutic Drug Monitoring|January 1, 1983
Optimization of pharmacokinetic monitoring: I. Linear pharmacokineticsM J Berg, R K Lantz, R D Schoenwald, et al.Pageof 3